About the Case Study
Pharm-Olam is currently partnering with a sponsor company in the development of a treatment for Glioblastoma / Anaplastic Astrocytoma. This type of brain tumor has very few available therapies, so this study’s goal is to assist in potentially identifying additional effective treatment options.
Sites & Locations:
60 across North America, Western Europe, and the Middle East
- Project Management
- Quality Assurance